1-6 of 6
Prakash S. Nagarkatti
Close
Sort by
Journal Articles

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

Robert J. McKallip, Catherine Lombard, Michael Fisher, Billy R. Martin, Seongho Ryu, Steven Grant, Prakash S. Nagarkatti, Mitzi Nagarkatti
Journal: Blood
Blood (2002) 100 (2): 627–634.
https://doi.org/10.1182/blood-2002-01-0098
Published: 2002
Journal Articles

Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas + organs

Ahmet Zeytun, Mitzi Nagarkatti, Prakash S. Nagarkatti
Journal: Blood
Blood (2000) 95 (6): 2111–2117.
https://doi.org/10.1182/blood.V95.6.2111
Published: 2000
Journal Articles

Role of Spontaneous and Interleukin-2–Induced Natural Killer Cell Activity in the Cytotoxicity and Rejection of Fas + and Fas − Tumor Cells

Mike Bradley, Ahmet Zeytun, Asimah Rafi-Janajreh, Prakash S. Nagarkatti, Mitzi Nagarkatti
Journal: Blood
Blood (1998) 92 (11): 4248–4255.
https://doi.org/10.1182/blood.V92.11.4248
Published: 1998
Journal Articles

Fas-Fas Ligand–Based Interactions Between Tumor Cells and Tumor-Specific Cytotoxic T Lymphocytes: A Lethal Two-Way Street

Ahmet Zeytun, Mona Hassuneh, Mitzi Nagarkatti, Prakash S. Nagarkatti
Journal: Blood
Blood (1997) 90 (5): 1952–1959.
https://doi.org/10.1182/blood.V90.5.1952
Published: 1997
Journal Articles

Hyaluronate-CD44 Interactions Can Induce Murine B-Cell Activation

Asimah Rafi, Mitzi Nagarkatti, Prakash S. Nagarkatti
Journal: Blood
Blood (1997) 89 (8): 2901–2908.
https://doi.org/10.1182/blood.V89.8.2901
Published: 1997
Journal Articles

Evidence for the Participation of Interleukin-2 (IL-2) and IL-4 in the Regulation of Autonomous Growth and Tumorigenesis of Transformed Cells of Lymphoid Origin

Mona R. Hassuneh, Prakash S. Nagarkatti, Mitzi Nagarkatti
Journal: Blood
Blood (1997) 89 (2): 610–620.
https://doi.org/10.1182/blood.V89.2.610
Published: 1997